🇺🇸 FDA
Patent

US 7189828

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

granted A61KA61K38/08A61K38/14

Quick answer

US patent 7189828 (Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/08, A61K38/14